Skip to main content

14 February 2026

Last updated: Thursday 12 February 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Antisoma secures a marketing right as part of its licensing deal with Novartis

Saturday 10 November 2007

Interviewee/Contributor

Nicholas Adams

Organisation

Novartis

Organisations

Cancer Research UK
Probiodrug AG
Independent regulatory affairs professional
MedNous contributing editor
Oxford Biomedica Plc
Index Ventures Management LLP
Massachusetts General Hospital
Shore Capital Ltd
Anergis SA
Oryx GmbH & Co KG and Valo Therapeutics Ltd

Interviewees and Contributers

Angela Russell and Michael Stein
Alfred Bach
Shaun Grady
Pierre Meulien
Mark Vaeck
Nicholas Adams
Ruth McKernan
David Mott
Emanuel Björne
Friedrich von Bohlen

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

German biotech DISCO Pharmaceuticals appoints CEO

Monday 19 January 2026

argenx in CEO transition

Monday 19 January 2026

PureTech Health appoints CEO

Monday 19 January 2026

New CEO at Tacalyx

Monday 19 January 2026

Tubulis appoints oncology expert as CMO

Monday 19 January 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form